tocainide has been researched along with hydantoins in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M | 1 |
| Axelson, JE; Kwok, DW; McErlane, KM | 1 |
| Axelson, JE; Venkataramanan, R | 1 |
3 other study(ies) available for tocainide and hydantoins
| Article | Year |
|---|---|
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship | 2008 |
A gas chromatographic assay for tocainide carbamoyl-O-beta-D-glucuronide:quantitation of the base hydrolyzed product, 3-(2',6'-xylyl)-5-methylhydantoin.
Topics: Adult; Anti-Arrhythmia Agents; Calibration; Chromatography, Gas; Gas Chromatography-Mass Spectrometry; Half-Life; Humans; Hydantoins; Hydrolysis; Lidocaine; Male; Reproducibility of Results; Sodium Hydroxide; Tocainide | 1990 |
3-(2,6-Xylyl)-5-methylhydantoin--a metabolite or a metabonate of tocainide in rats.
Topics: Animals; Biotransformation; Drug Stability; Hydantoins; Lidocaine; Male; Rats; Tocainide | 1981 |